Godrej Agrovet’s Oil Palm business is emerging as one of the company’s most significant long-term value drivers, with management pursuing a combination of acreage expansion, plantation maturation, operating efficiencies and downstream value addition. The segment reported strong growth in Q1 FY27, with revenue increasing 28.9% year-on-year and segment results rising 14.4%.
The investment thesis became interesting when Kotak Institutional Equities highlighted Oil Palm as a potential “hidden gem” stock and mentioned that even the standalone business might have been worth more than the market cap of Godrej Agrovet Ltd. In fact, Kotak has increased its valuation multiple on the segment from 15x EBITDA to 18x EBITDA.
The big question now lies in whether the bottom-line growth will be sustained at these multiples. With a market cap of Rs 13,000 crore, the shares of Godrej Agrovet Ltd are trading at Rs 674 and are trading at a PE of 28 compared to their industry’s PE of 21.
Oil Palm Emerges as a Key Valuation Driver
The Kotak thesis hinges on the earnings potential of oil palm over the next few years. Kotak sees oil palm EBITDA at around Rs 430 crore in FY26 and Rs 1,000 crore-plus in FY31, marking an almost 2x CAGR. The forecast is made based on forecasts of volume growth and value additions through higher-margin products. The guidance provided by management offers credibility to the forecast assumptions.
Over the next four to five years, management sees volumes growing in a high single-digit to early double-digit range. This would be driven by various levers: acreage growth, geographical diversification, maturity of plantations and efficiency improvements. The company’s unique addressable market stems from this multi-year perspective, where volume growth assumptions backed by clear operational plans become central to valuation.
Acreage Expansion Provides Long-Term Volume Visibility
Another key element of the oil palm strategy entails the growth of the plantation footprint. The management aims to grow oil palm plantations from 80,000 hectares to 150,000 hectares, which translates to almost 2X. Much of this incremental area would come from locations such as Telangana and the Northeast, thus enabling geographical diversification.
This growth process is already underway. Godrej Agrovet expanded by 17,000 hectares in the last year and continues expanding at a similar pace in the current year. The company mentioned that it is executing well ahead of its own plans in terms of expansion regarding area in Q1 FY27. As a result, there would be an increasingly larger plantation base to support future production growth.
Maturing Plantations Could Accelerate Production
The age profile of the plantation base represents another growth lever worth highlighting. According to management guidance, roughly 50% of the company’s plantations are currently aged between zero and four years, considered the juvenile stage. They will be ready to produce after four years, achieving peak productivity after eight years.
This represents another source of growth, unrelated to any additional planting of acres. Existing juvenile plantations that mature naturally imply growing productivity out of the same planted acres. Hence, together with the expansion of new planting of acres, this implies two sources of growth for volume increases, enabling the high single-digit to low double-digit FFB growth forecast by management.
Operating Efficiency Adds Another Layer to Growth
Oil palm’s strategy does not hinge purely on raising volumes of fresh fruit bunches (FFBs). In addition, the management noted that there had been consistent improvements in operating efficiencies, especially relating to oil extraction ratios (OERs). According to management, they have continued to post impressive OER numbers, and their OER in Q1 FY27 was superior to what they posted in the corresponding quarter last year.
That aspect was clearly evident during Q1 FY27 itself. Despite having broadly flat volumes of FFB relative to a very tough base, revenues grew by 28.9%, whereas segment profits climbed 14.4%. As per management commentary, this performance could be attributed to better realisations of both crude palm oil (CPO) and processed kernel oil (PKO), along with volume sales growth, alongside oil extraction efficiencies.
The Business Is Moving Towards Value Addition
Godrej Agrovet is also seeking to transform its oil palm business, shifting away from a traditional upstream-orientated plantation-based approach toward a complete end-to-end model. According to management, the company initiated the transformation process by creating an integrated palm oil complex, starting off with a nursery and a CPO milling plant. The next phase involves constructing a seed garden and refining facility once the project expands further.
Meanwhile, the firm plans to move into specialty fats as well. As per management, the rollout of the company’s first specialty fats refinery will happen around September 2026. The initiative will help the company convert some proportion of its palm oil into specialty fats consumed by the food sector. With scaling, management believes the downstream division could add roughly 200 basis points to Godrej Agrovet’s consolidated EBITDA profile.
Why Margins Matter to the Valuation
A valuation case could also be made when Oil Palm manages to drive volume growth along with profitability. According to Kotak, historical EBITDA margins for oil palm range between 15% and 23%, and there are opportunities for enhancement based on leverage effects and better contribution margin ratios from higher OER. This is significant since merely growing the earnings base does not automatically translate into a premium multiple; how sustainable and robust the earnings stream is matters too.
The capital allocation policy adopted by management also points towards the fact that the firm still views ROIC as an essential aspect of decision-making. Oil Palm itself categorises the investment as a high ROCE proposition, with required IRR thresholds for investment decisions at roughly 16-18%. Therefore, any planned growth appears to have a return requirement and is not acreage-led growth alone.
The 18x Multiple Creates the Valuation Upside
Valuation starts with the multiple assigned to each individual segment. Kotak has marked up the oil palm segment multiple from a 15x to an 18x EV/EBITDA multiple. Kotak’s internal discounted cash flow model suggests a range that is higher still; around 20x EV/EBITDA may be warranted on account of growth potential and profitability.
Multiplying the FY31 EBITDA guidance figure by the multiple of 18x provides an indicative EV in excess of Rs 18,000 crore. In contrast, the current stock price implies a market cap that is substantially lower than this figure for Godrej Agrovet. However, this analysis must necessarily remain theoretical, since enterprise value is distinct from market cap, and Kotak hasn’t indicated any valuation of Rs 18,000 crore or more for Oil Palm equity alone.
Risks Could Challenge the Valuation Thesis
Oil palm continues to be vulnerable to climatic factors and commodity prices. Management called attention to the seasonal nature of FFB production in the guidance note. Rainfall patterns would lead to considerable variations in quarterly output levels. During Q1 FY27, FFB production was largely consistent, owing to favorable monsoon rains in the comparative quarter. The guidance statement, therefore, stressed the need to evaluate oil palm based on a year-on-year perspective, rather than on a quarterly basis.
Execution risks arise in relation to the proposed capacity expansions and value-added initiatives within Downstream. There is a requirement to execute on new plantation growth successfully, mature existing juvenile plantations into economically viable stages, sustain any OER efficiency gains and scale down specialty fats’ production operations. Although management is confident of achieving a minimum IRR of 16-18% on oil palm projects; it will still depend on successful execution and scalability.
Can Oil Palm Be Worth More Than Godrej Agrovet?
Godrej Agrovet’s Oil Palm business appears to assume increasing importance within the valuation thesis of Godrej Agrovet itself. When Kotak Institutional Equities made its valuation call, the market cap of Godrej Agrovet stood at roughly Rs 11,800 crore. Against this backdrop, Kotak made the claim that the Oil Palm business alone was likely to be worth in excess of the market cap of Godrej Agrovet itself.
According to Kotak, EBITDA from the Oil Palm business is expected to grow from approximately Rs 430 crore in FY26 to in excess of Rs 1,000 crore by FY31. In addition to that, Kotak revised the multiple for the Oil Palm business up from 15x EV/EBITDA to 18x EV/EBITDA. A straightforward illustration of numbers: an EBITDA run rate of Rs 1,000 crore at an 18x multiple results in an enterprise value of roughly Rs 18,000 crore, significantly in excess of the Rs 11,800 crore market cap at the time of valuation of Godrej Agrovet.
However, the Rs 18,000 crore figure is not Kotak’s stated standalone valuation for the Oil Palm business and should not be presented as one. It is an illustrative calculation using Kotak’s FY31 EBITDA estimate and 18x multiple. Whether oil palm can actually become more valuable than the company will ultimately depend on the business achieving the projected EBITDA growth, supported by a near-doubling of acreage, maturing plantations, improving OER and downstream value addition, while continuing to command a premium valuation multiple.